he intensive care unit (ICU) [1]. Fluid resuscitation is a relevant topic in critical care and the debate on optimal fluid management is evolving. Hydroxyethyl starch (HES) is a colloid used for volume replacement therapy with a controversial history: recently HES-derived products' market authorizations have been reevaluated and more restrictive rules have been released [2-5]. In the United States, the Food and Drug Administration has been requested to withdraw HES-based products by Public Citizen, a nonprofit consumer advocacy organization [2,3]. I
Hydroxyethyl starch and fluid resuscitation. Patient-oriented outcome is the “right way” / Giordano, G.; Pugliese, F.; Bilotta, F.. - In: JOURNAL OF CRITICAL CARE. - ISSN 0883-9441. - 51:(2019), pp. 227-227. [10.1016/j.jcrc.2019.02.012]
Hydroxyethyl starch and fluid resuscitation. Patient-oriented outcome is the “right way”
Giordano G.
;Pugliese F.;Bilotta F.
2019
Abstract
he intensive care unit (ICU) [1]. Fluid resuscitation is a relevant topic in critical care and the debate on optimal fluid management is evolving. Hydroxyethyl starch (HES) is a colloid used for volume replacement therapy with a controversial history: recently HES-derived products' market authorizations have been reevaluated and more restrictive rules have been released [2-5]. In the United States, the Food and Drug Administration has been requested to withdraw HES-based products by Public Citizen, a nonprofit consumer advocacy organization [2,3]. I| File | Dimensione | Formato | |
|---|---|---|---|
|
Giordano_Hydroxyethyl-starch_2019.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
86.48 kB
Formato
Adobe PDF
|
86.48 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
